is tirzepatide coming off the shortage list FDA confirms still over, gives compounders a grace period Compounded Tirzepatide: Legal & Safe
Description
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach

Eli Lilly and Company has registered its intent to carry out a Phase 3b clinical trial that will see the companys tirzepatide (Mounjaro) compared with Novo Nordisks semaglutide (Wegovy) 2.4mg in 700 adult participants who have obesity or overweight with weight related comorbidities without Type 2 diabetes

Falling prices for key starting materials (KSMs) 3
The DEA is opening the question of a kratom ban up to public comment until December 1

Batch COA reports 99.72% HPLC-UV purity, LC-MS identity confirmed and 11.35mg net content.
